Navigation Links
Heart-Assist Device Gives Culver City Man a Good Quality of Life

Mark Heiner of Culver City reads books, paints artistically, takes walks and does laundry activities that would be considered routine except for the fact that a four-pound disk implanted in his abdominal cavity is keeping his blood flowing.

The procedure to implant the Thoratec HeartMate XVE was performed in early March by a team led by cardiothoracic surgeon Sinan A. Simsir, M.D., surgical director of the Heart Transplant and Ventricular Assist Device Program at Cedars-Sinai Medical Center.

Heiners implantation of the XVE may be the first in Los Angeles County. The device was approved by the Food and Drug Administration in 2002 for use in destination therapy, permanent support for end-stage heart failure patients who are not eligible for heart transplantation.

Heiner, 57, a former prop man in the entertainment industry, has a history of cardiomyopathy, in which the heart becomes enlarged and less efficient. He also was diagnosed in 1999 with non-Hodgkins lymphoma, cancer of the lymph nodes. When he had a lymphoma relapse in 2005, a course of chemotherapy further damaged his heart.

The combination of ailments left Heiner in a medical Catch-22. His heart was so weak he needed a transplant, but guidelines of the International Society of Heart & Lung Transplantation suggest a patient be tumor-free for five years before being subjected to the immunosuppression that reduces the risk of organ rejection.

I was very sick. I couldnt even be out of bed for very long. I was in intensive care about nine months ago and I got through that but my heart just never came back, Heiner said. I was fatigued, couldnt breathe and couldnt concentrate. I just wasnt getting enough blood throughout my body. I was very close to death.

A left ventricular assist device (LVAD), the HeartMate XVE assumes the work of the hearts left ventricle, the main pumping chamber of the heart. The mechanical device can pump u
'"/>




Page: 1 2 3

Related medicine news :

1. Injection supports Heart Devices
2. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
3. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. New Implantable Device That Can Keep The Heart Ticking
6. Making MRIs Safe for Patients With Implantable Heart Devices
7. Researchers Develop Device For Detecting Atherosclerotic Plaques
8. A Cheap Device to Stop Snoring from New Zealand
9. Scientists Concerned Over Increasing Malfunction Of Heart Devices
10. Device For Improving Bone Mass In Osteoporosis
11. Anti-Microbial Coating For Use Over Biomedical Devices Developed
Post Your Comments:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
...ng anthocyanin molecules could lead to new treatme...) -- Compounds called anthocyanins, which give col...les, may help protect against colon cancer, an Ohi...y slow the growth of colon cancer cells. The team ...
...ors of cardiovascular trouble, study found , FRIDA...gs down a number of "biological indicators" pointi...y shows. , The indicators include autonomic dysfun...ory and Critical Care Medicine . , "This study pro...
... sleep routine at least a week before classes star...he new school year starts, youngsters should start...don,t, they could end up suffering a sleep deficit... once a schedule has been established, it may take...
...eposits of fat on the chest and back is associate...condition that is a precursor of type 2 diabetes, ... Francisco VA Medical Center (SFVAMC). , It is t... HIV negative control subjects in the Study of Fat...
...e now diagnosed as having depression? Two experts ...ordon Parker, a psychiatrist from Australia says t...clinical depression is too low. He fears it could...d 242 teachers. Fifteen years into the study, 79%...
...e (hypertension) is associated with an increased r...se of drugs known as NSAIDs, for example to treat ...ypertension. Exactly why NSAIDs cause hypertension...of inhibiting the individual receptors for prostag...
Other Medicine News:Health News:Urban Smog Tough on Young Adults' Hearts 2Health News:Add Earlier Bedtime to Back-to-School List 2Health News:Fat on chest and upper back increases risk of insulin resistance 2Health News:Are too many people diagnosed as 'depressed?' 2
(Date:12/4/2009)WINSTON-SALEM, N.C., Dec. 4 A new, $2.8 million, four-year federal grant will support researchers at the University of Pittsburgh School of Medicine and their collaborators at Wake Forest University
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Providing Comfort for Holiday Guests Just Got Easier 62103 1Providing Comfort for Holiday Guests Just Got Easier 62103 2Providing Comfort for Holiday Guests Just Got Easier 62103 3New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 1New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 2New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 3realbuzz com Top 25 Ways to Improve Your Health 26amp 3B get a Better Sex Life 21 62093 1realbuzz com Top 25 Ways to Improve Your Health 26amp 3B get a Better Sex Life 21 62093 2
...H SAN FRANCISCO, Calif., April 11, 2007 (PRIME NEW...rmaceutical company focused,on advancing cancer ca... (talotrexin) for Injection at the American Associ...il 14-18, 2007 in Los,Angeles, California. , Abstr...paclitaxel in A549 non-small cell lung cancer (NSC...
...EWATER, N.J.--(BUSINESS WIRE)--Apr 12, 2007 - Enzo...oday that four,posters containing preclinical data...he American Association for Cancer Research,(AACR)...s, CA., Details of the presentations are as follow...leneglycol-SN38,conjugate, has potent antitumor ac...
Other Medicine Technology:Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3Enzon to Present Preclinical Data From PEG-SN38 and PEGylation,Technology Studies at AACR Meeting 2
...stainer is an "assembly-line worker" for routine s...nd cytology laboratories. Programmable continuous ... stains big quantities of slides in short time. It...with a continuous working principle provides a hig...
Cholesterol (Single reagent)
Cholesterol Reagent Set
Omega 16ic
Medicine Products: